Search - tctmd.com

Displaying 41 - 60 of 260

Sort: Relevancy | Date

Presentation TCT 2017

Utility of Genotyping and Platelet Function Testing to Guide Antiplatelet Therapy: 2017 Assessment

Presenter: Dominick J. Angiolillo, Marco Valgimigli, Thomas Engstroem

October 30, 2017

Presentation TCT 2017

Alternatives to Traditional P-value Testing: Bayesian Designs

Presenter: Eugene H. Blackstone, Stuart J. Pocock, Roseann M White

October 30, 2017

Presentation TCT 2017

Uncontrolled Hypertension Management Issues: Adherence, Testing, and Difficult Patient Scenarios

Presenter: Sidney C. Smith, Michael A. Weber

October 30, 2017

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

News Daily News

Lp(a) Not Associated With Adverse Cardiovascular Events in ACS Patients

Michael O'Riordan

October 26, 2017

Podcast Heart Sounds

Preventing Dementia May Be Another Reason to Take Oral Anticoagulants for A-fib

Todd Neale

October 25, 2017

News Daily News

Applying the AUC: Teaching, Screening Make a Difference in Unneeded Invasive Tests

Caitlin E. Cox

October 24, 2017

News Daily News

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

Todd Neale

October 23, 2017

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Daily News

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Yael L. Maxwell

October 20, 2017

News Daily News

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Michael O'Riordan

October 19, 2017

News Daily News

What Works, What Matters? Patient-Centered Endpoints Gain Traction in CV Clinical Trials

Caitlin E. Cox

October 13, 2017

News Daily News

Multiarterial CABG Gets a Boost in Retrospective Analysis

Yael L. Maxwell

October 12, 2017

News Daily News

Merck Calls Quits on CETP Inhibitor Anacetrapib

Michael O'Riordan

October 12, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

News Daily News

High-Sensitivity Troponin Tests Still Useful in Patients With Renal Dysfunction and Suspected ACS, With Caveats

Yael L. Maxwell

October 06, 2017

News Daily News

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

Caitlin E. Cox

October 06, 2017

News Daily News

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Michael O'Riordan

October 05, 2017

Advertisement

Utility of Genotyping and Platelet Function Testing to Guide Antiplatelet Therapy: 2017 Assessment

Alternatives to Traditional P-value Testing: Bayesian Designs

Uncontrolled Hypertension Management Issues: Adherence, Testing, and Difficult Patient Scenarios

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Lp(a) Not Associated With Adverse Cardiovascular Events in ACS Patients

Top Stories in Cardiology, October 2017

Preventing Dementia May Be Another Reason to Take Oral Anticoagulants for A-fib

Applying the AUC: Teaching, Screening Make a Difference in Unneeded Invasive Tests

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

What Works, What Matters? Patient-Centered Endpoints Gain Traction in CV Clinical Trials

Multiarterial CABG Gets a Boost in Retrospective Analysis

Merck Calls Quits on CETP Inhibitor Anacetrapib

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

High-Sensitivity Troponin Tests Still Useful in Patients With Renal Dysfunction and Suspected ACS, With Caveats

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content